Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the ...

JPMorgan upgraded Bluebird Bio (BLUE) to Neutral from Underweight without a price target after the company entered into a definitive agreement ...

12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

Bluebird is the 'brainchild' of locals Andy Daintree and Ian Scott - also known as Scottie. They felt Wedmore needed a community café and a place to showcase South West music talent and the bar has ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...

AST SpaceMobile (NASDAQ: ASTS), a producer of low earth orbit (LEO) satellites for cellular networks, saw its stock soar more ...

D&D London has announced plans to rebrand as the Evolv Collection in April. It comes after the restaurant group was sold to ...

Reimagining Simon Stephens' 2015 play a decade later, Katharine Farmer's new direction of Heisenberg reinterprets the story ...

Kentucky has had its fair share of representation and success on NBC’s “The Voice” including Harlan native Jordan Smith’s win ...

The powdery snow that skiers and snowboarders love, especially on crystal clear days, plays a big role in how much your skin ...

Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...